With diabetes cases worldwide expected to double in the first 30 years of the 21st century, telemedicine might be a pathway to ensuring that more patients receive care, and thus, prevent complications from retinopathy.
With diabetes cases worldwide expected to double in the first 30 years of the 21st century, telemedicine might be a pathway to ensuring that more patients receive care, and thus, prevent complications from retinopathy, said P. Lloyd Hildebrand, MD, Dean A. McGee Eye Institute, Oklahoma University Health Sciences Center, US.
“Remote retinal imaging with centralized interpretation allows for increased access, quality, and efficiency,” he said. This is especially true for a largely rural population.Putting together a telemedicine programme is not easy, however, Dr Hildebrand said. He offered a 10-step approach:
1. Decide whether you want to target detection or diagnostic evaluation. This knowledge will affect the protocols and technologies you’ll implement.2. Plan to measure the quality of your efforts through five parameters: reproducibility, technical referral rate, number of ungradeable eyes, accuracy, and compliance.3. Develop a viable business model. “This may be the biggest problem to developing a program, especially in the United States,” Dr Hildebrand said. “Margins are tight, and you're dealing with highly variable health plan reimbursement policies.”4. Generate useful reports.5. Push compliance. Programmes that drive compliance, such as disease registries and call systems, will be important.6. Educate, educate, educate. Because much of diabetes is a primary care disease, enlist the help of primary care physicians to inform patients about the seriousness of diabetic retinopathy and to encourage them to participate.7. Plan for the outliers - you will encounter patients who have other pathologies.8. Provide a solution; have an outlet to provide treatment.9. Understand the barriers, whether those are geographical, governmental, or something else.10. Understand that many questions about retinopathy remain to be answered.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.